Rockefeller Financial Services’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Rockefeller Financial Services’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,203	Closed	-$17K	–	511
2015 Q1	$17K	Hold	1,203	–	–	﹤0.01%	468
2014 Q4	$20K	Sell	1,203 -2	-0.2%	-$29	﹤0.01%	431
2014 Q3	$16K	Hold	1,205	–	–	﹤0.01%	439
2014 Q2	$15K	Hold	1,205	–	–	﹤0.01%	500
2014 Q1	$14K	Hold	1,205	–	–	﹤0.01%	469
2013 Q4	$17K	Hold	1,205	–	–	﹤0.01%	447
2013 Q3	$21K	Hold	1,205	–	–	﹤0.01%	448
2013 Q2	$20K	Buy	+1,205	New	+$37.3K	﹤0.01%	447

Other funds holding INFI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Rockefeller Financial Services's INFI Position: Q2 2015 in Review

Rockefeller Financial Services sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2015, closing a stake of 1,203 shares — an estimated $17K sold.

Rockefeller Financial Services first reported a position in INFI in Q2 2013 and held it in 8 quarters. The position peaked at $21K in Q3 2013. 137 funds tracked by Wall St. Rank hold INFI as of Q2 2015.

Rockefeller Financial Services reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
Rockefeller Financial Services sold 1,203 Infinity Pharmaceuticals, Inc. shares in Q2 2015, an estimated $17K.
Rockefeller Financial Services first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 8 quarters.
Rockefeller Financial Services's Infinity Pharmaceuticals, Inc. position peaked at $21K in Q3 2013.
137 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2015.

Based on Rockefeller Financial Services's 13F filing for Q2 2015, filed 14 Jul 2015.